Clinical trial
Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary…
NCT00379730 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00379730 |
|---|---|
| Title | Prednisolone Novel Endpoint Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Official title | A Randomized, Double-blind Study of Treatment With a Known Anti-inflammatory (Prednisolone) to Evaluate Novel Endpoints in Patients With Chronic Obstructive Pulmonary Disease (COPD) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | Prednisolone |
| Enrollment | 90 |
| Start date | Mar 21, 2006 |
| Completion | May 3, 2007 |
| First posted | Sep 22, 2006 |
| Last update posted | Jul 11, 2017 |
| Countries | Argentina, Chile, New Zealand, South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: